Drew M. Pardoll

165.7k citations

403 papers · 83.2k indexed · 42 hit papers · h-index 132

Impact in

Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions

Papers in

Immunology 259
- Immunotherapy and Immune Responses 181
- Immune Cell Function and Interaction 110
- T-cell and B-cell Immunology 77
Oncology 216
- Cancer Immunotherapy and Biomarkers 146
- CAR-T cell therapy research 78

Co-authors: Suzanne L. Topalian Charles G. Drake Hua Yu Janis M. Taube Richard Jove Robert A. Anders Elizabeth M. Jaffee Marcin Kortylewski
Journals: Journal of Clinical Oncology (27 papers)Cancer Research (26 papers)The Journal of Immunology (25 papers)The Journal of Experimental Medicine (15 papers)Nature Medicine (13 papers)
Partner nations: United States Japan Taiwan

In The Last Decade

Drew M. Pardoll

397 papers receiving 81.6k citations

Hit Papers

15 papers align trajectories log scale

Cancer therapy with antibodies 2024 · 102 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature reviews. Cancer
2023 Cancer Cell
2020 Science
2019 JAMA Oncology
2019 Journal for ImmunoTherapy of Cancer
2018 Science
2016 Science
2016 Nature reviews. Cancer
2015 Science Translational Medicine
2015 Cancer Cell
2014 Clinical Cancer Research
2014 Cancer Discovery
2014 Clinical Infectious Diseases
2013 Cancer Research
2012 Science Translational Medicine
2012 Nature reviews. Cancer
2012 Current Opinion in Immunology
2011 Cell
2010 Journal of Clinical Oncology
2009 Nature reviews. Cancer
2009 The Journal of Experimental Medicine
2009 Cancer Cell
2009 Nature Medicine
2006 Advances in immunology
2006 Nature reviews. Immunology
2005 Nature Medicine
2004 Immunity
2003 Nature Medicine
2003 Annual Review of Immunology
2002 Oncogene
2002 The Journal of Immunology
2001 The Journal of Experimental Medicine
1998 Proceedings of the National Academy of Sciences
1998 Current Opinion in Immunology
1998 The Journal of Experimental Medicine
1996 PubMed
1994 Science
1993 Proceedings of the National Academy of Sciences
1991 Science
1990 Cell
1980 Cell
1980 Cell

Peers

Countries citing papers authored by Drew M. Pardoll

Since Specialization

Citations

This map shows the geographic impact of Drew M. Pardoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew M. Pardoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew M. Pardoll more than expected).

Fields of papers citing papers by Drew M. Pardoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew M. Pardoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew M. Pardoll. The network helps show where Drew M. Pardoll may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Drew M. Pardoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Drew M. Pardoll Line = papers co-authored together Drew M. Pardoll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors Clinical Cancer Research ·Fyza Y. Shaikh, James R. White, Joell J. Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jeffrey S. Weber, Jiyoung Ahn, Evan J. Lipson, Jarushka Naidoo, Drew M. Pardoll, Cynthia L. Sears	2021	27
2	Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy Cancer Immunology Research ·Nicolás J. Llosa, Brandon Luber, Nicholas Siegel, Pezeshki MahboobLessan, Brage Sundstrom, Qingfeng Zhu, Bjarne R. Bartlett, Laveet K. Aulakh, Elizabeth D. Thompson, Elizabeth M. Jaffee, Jennifer N. Durham, Cynthia L. Sears, Dung T. Le, Luis A. Díaz, Drew M. Pardoll, Hao Wang, Franck Housseau, Robert A. Anders	2019	32
3	PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function Cancer Immunology Research ·Sarah Whelan, Eran Ophir, Maya F. Kotturi, Ofer Levy, Sudipto Ganguly, Ling Yan Leung, Ilan Vaknin, Sandeep Kumar, Renate Goldmann, Kyle Hansen, M. de Vries, Paul. Auteur de lettres Labrouche, Abha Soni, Janis M. Taube, Amanda N. Fader, Tian‐Li Wang, Ie‐Ming Shih, Mark A. White, Drew M. Pardoll, Spencer C. Liang	2019	125
4	The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity Cancer Immunology Research ·Ludmila Danilova, Valsamo Anagnostou, Justina X. Caushi, John-William Sidhom, Haidan Guo, Hok Yee Chan, Prerna Suri, Ada Tam, Jiajia Zhang, Margueritta El Asmar, Kristen A. Marrone, Jarushka Naidoo, Julie R. Brahmer, Patrick M. Forde, Alexander S. Baras, Leslie Cope, Victor E. Velculescu, Drew M. Pardoll, Franck Housseau, Kellie N. Smith	2018	99
5	YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity Cancer Discovery ·Xuhao Ni, Jin‐Hui Tao, Joseph Barbi, Qian Chen, Benjamin V. Park, Zhiguang Li, Nailing Zhang, Andriana Lebid, Anjali Ramaswamy, Ping Wei, Ying Zheng, Xuehong Zhang, Xingmei Wu, Paolo Vignali, Cuiping Yang, Huabin Li, Drew M. Pardoll, Ling Lu, Duojia Pan, Fan Pan	2018	168
6	The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma Cancer Immunology Research ·Maria Libera Ascierto, Tracee L. McMiller, Alan E. Berger, Ludmila Danilova, Robert A. Anders, George J. Netto, Haiying Xu, Theresa S. Pritchard, Jinshui Fan, Chris Cheadle, Leslie Cope, Charles G. Drake, Drew M. Pardoll, Janis M. Taube, Suzanne L. Topalian	2016	133
7	Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis Cancer Discovery ·Abby L. Geis, Hongni Fan, Xinqun Wu, Shaoguang Wu, David L. Huso, 马玉洁, Cynthia L. Sears, Drew M. Pardoll, Franck Housseau	2015	142
8	Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination Clinical Cancer Research ·Christopher M. Jackson, Christina M. Kochel, Christopher J. Nirschl, Nicholas M. Durham, Jacob Ruzevick, Angela Alme, Brian J. Francica, Wang Xi-yua, Andrew Daniels, Thomas W. Dubensky, Peter Lauer, Dirk G. Brockstedt, Emily G. Baxi, Peter A. Calabresi, Janis M. Taube, Carlos A. Pardo, Henry Brem, Drew M. Pardoll, Michael Lim, Charles G. Drake	2015	54
9	PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation Cancer Immunology Research ·Nemanja Rodić, Robert A. Anders, James R. Eshleman, Ming-Tseh Lin, Haiying Xu, Jung Ho Kim, Katie Beierl, Shuming Chen, Brandon Luber, Hao Wang, Suzanne L. Topalian, Drew M. Pardoll, Janis M. Taube	2014	42
10	Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Clinical Cancer Research ·Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan, Jung Ho Kim, Lieping Chen, Drew M. Pardoll, Suzanne L. Topalian, Robert A. Anders Hit paper breakdown →	2014	1873
11	Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma Cancer Research ·Sofía Lyford-Pike, Shiwen Peng, Geoffrey D. Young, Janis M. Taube, William H. Westra, Belinda Akpeng, Tullia C. Bruno, Jeremy D. Richmon, Hao Wang, Justin A. Bishop, Lieping Chen, Charles G. Drake, Suzanne L. Topalian, Drew M. Pardoll, Sara I. Pai Hit paper breakdown →	2013	602
12	IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer Cancer Research ·Lin Wang, Tangsheng Yi, Wang Zhang, Drew M. Pardoll, Hua Yu	2010	146
13	Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model Cancer Research ·Satoshi Wada, Kiyoshi Yoshimura, Edward L. Hipkiss, Tim Harris, Hung‐Rong Yen, Monica V. Goldberg, Joseph F. Grosso, Derese Getnet, Angelo M. De Marzo, George J. Netto, Robert A. Anders, Drew M. Pardoll, Charles G. Drake	2009	122
14	Eos Mediates Foxp3-Dependent Gene Silencing in CD4 ⁺ Regulatory T Cells Science ·Fan Pan, Hong Yu, Eric V. Dang, Joseph Barbi, Xiaoyu Pan, Joseph F. Grosso, Ema Izzaila Ibrahim, Sudarshana M. Sharma, Jiawen Teng, Derese Getnet, Charles G. Drake, Jun O. Liu, Michael C. Ostrowski, Drew M. Pardoll	2009	245
15	Integrin α2 Mediates Selective Metastasis to the Liver Cancer Research ·Kiyoshi Yoshimura, Kristen F. Meckel, Anna D. Biedrzyńska, Christina Y. Chia, Jang‐June Park, Kelly Olino, Ryouichi Tsunedomi, Toshio HARADA, Norio Iizuka, Shoichi Hazama, Yukihiko Kato, Jesse W. Keller, John M. Thompson, Fumin Chang, Lewis H. Romer, Ajay Jain, Christine A. Iacobuzio–Donahue, Masaaki Oka, Drew M. Pardoll, Richard D. Schulick	2009	69
16	IFN-Producing Killer Dendritic Cells Are Antigen-Presenting Cells Endowed with T-Cell Cross-Priming Capacity Cancer Research ·Maria Pletneva, Hongni Fan, Jang‐June Park, Vedran Radojčić, Chunfa Jie, Yanxing Yu, Camie W. Chan, Alec Redwood, Drew M. Pardoll, Franck Housseau	2009	20
17	Live Attenuated Listeria Monocytogenes Effectively Treats Hepatic Colorectal Cancer Metastases and Is Strongly Enhanced by Depletion of Regulatory T Cells Cancer Research ·Kiyoshi Yoshimura, Anna D. Biedrzyńska, Christina Y. Chia, Kristen F. Meckel, Jill E. Slansky, John M. Thompson, Ajay Jain, Drew M. Pardoll, Richard D. Schulick	2007	29
18	Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion Cancer Research ·Elena Pacita Lois Garrido, Dan Lü, Chien‐Fu Hung, Shiwen Peng, Lanqing Huang, Chunfa Jie, F. Murillo, Jesse W. Rowley, Ya-Chea Tsai, Liangmei He, Dae‐Jin Kim, Elizabeth M. Jaffee, Drew M. Pardoll, T.‐C. Wu	2007	71
19	HLA-DQB102–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial Lesions Clinical Cancer Research* ·Shiwen Peng, Cornelia L. Trimble, Lee Wu, Drew M. Pardoll, Richard B.S. Roden, Chien‐Fu Hung, T.‐C. Wu	2007	61
20	Selective Targeting of Antitumor Immune Responses with Engineered Live-Attenuated Listeria monocytogenes Cancer Research ·Kiyoshi Yoshimura, Ajay Jain, Heather E. Allen, Anna D. Biedrzyńska, Christina Y. Chia, Sowmya Ravi, Dirk G. Brockstedt, Martin Giedlin, Keith S. Bahjat, Meredith L. Leong, Jill E. Slansky, David N. Cook, Thomas W. Dubensky, Drew M. Pardoll, Richard D. Schulick	2006	48

About Drew M. Pardoll

Drew M. Pardoll is a scholar working on Immunology, Oncology, Biotechnology, Otorhinolaryngology and Cancer Research, having authored 403 papers that have together received 83.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (181 papers), Cancer Immunotherapy and Biomarkers (146 papers), Immune Cell Function and Interaction (110 papers), CAR-T cell therapy research (78 papers), T-cell and B-cell Immunology (77 papers), Virus-based gene therapy research (30 papers), Cancer Research and Treatments (24 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). The work is most often cited by research in Immunology (46.7k citations), Oncology (45.0k citations), Cancer Research (6.7k citations), Molecular Biology (23.5k citations) and Biotechnology (2.9k citations). Drew M. Pardoll has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Suzanne L. Topalian, Charles G. Drake, Hua Yu, Janis M. Taube, Richard Jove, Robert A. Anders, Elizabeth M. Jaffee, Marcin Kortylewski, Lieping Chen and Hyam I. Levitsky. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Journal of Immunology, The Journal of Experimental Medicine and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact